Swiss National Bank - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 97 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.84 and the average weighting 1.2%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$609,908
-34.3%
192,400
+3.0%
0.00%
-100.0%
Q2 2023$928,396
+0.6%
186,8000.0%0.00%0.0%
Q1 2023$922,792
-29.6%
186,800
-10.4%
0.00%0.0%
Q4 2022$1,310,836
-40.6%
208,400
+2.0%
0.00%
-50.0%
Q3 2022$2,206,000
-4.1%
204,300
+1.2%
0.00%0.0%
Q2 2022$2,301,000
+36.2%
201,800
+8.8%
0.00%
+100.0%
Q1 2022$1,689,000
-34.2%
185,400
+7.8%
0.00%
-50.0%
Q4 2021$2,566,000
-41.9%
172,0000.0%0.00%
-33.3%
Q3 2021$4,420,000
-0.6%
172,000
+0.9%
0.00%0.0%
Q2 2021$4,447,000
-12.6%
170,500
+18.2%
0.00%0.0%
Q1 2021$5,090,000
+42.3%
144,200
+1.8%
0.00%0.0%
Q4 2020$3,577,000
-25.8%
141,700
+10.9%
0.00%
-25.0%
Q3 2020$4,819,000
-10.3%
127,800
+1.9%
0.00%
-20.0%
Q2 2020$5,370,000
+483.7%
125,400
+165.1%
0.01%
+400.0%
Q1 2020$920,000
-24.0%
47,300
+1.5%
0.00%0.0%
Q4 2019$1,211,000
-1.7%
46,600
+3.1%
0.00%0.0%
Q3 2019$1,232,000
+1.5%
45,2000.0%0.00%0.0%
Q2 2019$1,214,00045,2000.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$5,700,1778.82%
Wildcat Capital Management, LLC 1,920,787$6,088,8952.44%
TPG GP A, LLC 18,716,306$59,330,6901.02%
EcoR1 Capital, LLC 4,488,200$14,227,5940.48%
CROSSPOINT FINANCIAL, LLC 12,000$38,0400.40%
Coastal Bridge Advisors, LLC 406,847$1,289,7050.35%
CAXTON ASSOCIATES LP 480,104$1,521,9300.21%
Woodline Partners LP 5,313,915$16,845,1110.20%
Rhenman & Partners Asset Management AB 300,000$951,0000.10%
Navalign, LLC 75,365$238,9070.09%
View complete list of ALLOGENE THERAPEUTICS INC shareholders